Perrigo Company plc (LON:0Y5E)

Market Cap	2.73B
Revenue (ttm)	3.28B
Net Income (ttm)	-119.10M
Shares Out	n/a
EPS (ttm)	-0.87
PE Ratio	n/a
Forward PE	n/a
Dividend	0.86 (3.40%)
Ex-Dividend Date	Mar 7, 2025

Volume	217
Average Volume	726
Open	25.20
Previous Close	25.39
Day's Range	25.18 - 25.45
52-Week Range	25.18 - 40.01
Beta	0.54
RSI	55.52
Earnings Date	Feb 27, 2025

About Perrigo Company

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health pr...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1887
• Employees: 9,140
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Y5E

Financial Performance

In 2023, Perrigo Company's revenue was $4.66 billion, an increase of 4.58% compared to the previous year's $4.45 billion. Losses were -$12.70 million, -90.97% less than in 2022.

Financial numbers in USD